PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Octreotide acetate
Presentation Product Chemical substance Chapter Items dispensed
Octreotide 100micrograms/1ml solution for injection ampoules
0803043N0AAABAB
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 244
Octreotide 500micrograms/1ml solution for injection ampoules
0803043N0AAACAC
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 227
Octreotide 30mg inj vials
0803043N0AAAFAF
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 104
Octreotide 20mg inj vials
0803043N0AAAGAG
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 90
Octreotide 100micrograms/1ml inj pre-filled syringes
0803043N0AAAPAP
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 88
Octreotide 50micrograms/1ml solution for injection ampoules
0803043N0AAAAAA
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 72
Octreotide 50micrograms/1ml inj pre-filled syringes
0803043N0AAANAN
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 57
Octreotide 1mg/5ml solution for injection vials
0803043N0AAADAD
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 56
Octreotide 500micrograms/1ml solution for injection vials
0803043N0AAAMAM
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 24
Octreotide 10mg inj vials
0803043N0AAAEAE
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 19
Octreotide 500micrograms/1ml inj pre-filled syringes
0803043N0AAAQAQ
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 17
Octreotide 100micrograms/1ml solution for injection vials
0803043N0AAALAL
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression 11
Octreotide 50micrograms/1ml solution for injection vials
0803043N0AAAKAK
Octreotide acetate Octreotide acetate Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.